Obese/diabetic mothers present a higher risk to develop offspring with myelomeningocele (MM), evidence supporting the role of energy homeostasis-related genes in neural tube defects. Using polymerase chain reaction–restriction fragment length polymorphism, we have genotyped SLC2A1, HK1, and LEPR single-nucleotide polymorphisms in 105 Chilean patients with MM and their parents in order to evaluate allele–phenotype associations by means of allele/haplotype transmission test (TDT) and parent-of-origin effects. We detected an undertransmission for the SLC2A1 haplotype T-A (rs710218-rs2229682; P = .040), which was not significant when only lower MM (90% of the cases) was analyzed. In addition, the leptin receptor rs1137100 G allele showed a significant increase in the risk of MM for maternal-derived alleles in the whole sample (2.43-fold; P = .038) and in lower MM (3.20-fold; P = .014). Our results support the role of genes involved in energy homeostasis in the risk of developing MM, thus sustaining the hypothesis of diverse pathways and genetic mechanisms acting in the expression of such birth defect.
GutierrezFRWoodardPKFleishmanMJ. Normal anatomy and congenital anomalies of the spine and spinal cord. In: OsbornAGMaackH, eds. Diagnostic Neuroradiology. St. Louis, MO: Mosby; 1994:785–819.
Tortori-DonatiPRossiACamaA. Spinal dysraphism: a review of neuroradiological features with embryological correlations and proposal for a new classification. Neuroradiology. 2000;42(7):471–491.
5.
CortésFMelladoCPardoRAVillarroelLAHertrampfE. Wheat flour fortification with folic acid: changes in neural tube defects rates in Chile. Am J Med Genet A. 2012;158A(8):1885–1890.
6.
López-CameloJSCastillaEEOrioliIM; INAGEMP (Instituto Nacional de Genética Médica Populacional); ECLAMC (Estudio Colaborativo Latino Americano de Malformaciones Congénitas). Folic acid flour fortification: impact on the frequencies of 52 congenital anomaly types in three South American countries. Am J Med Genet A. 2010;152A(10):2444–2458.
7.
BottoLDMooreCAKhouryMJEricksonJD. Neural-tube defects. N Engl J Med. 1999;341(20):1509–1519.
8.
AuKSAshley-KochANorthrupH. Epidemiologic and genetic aspects of spina bifida and other neural tube defects. Dev Disabil Res Rev. 2010;16(1):6–15.
9.
HarrisMJJuriloffDM. Mouse mutants with neural tube closure defects and their role in understanding human neural tube defects. Birth Defects Res A Clin Mol Teratol. 2007;79(3):187–210.
10.
GreenR.Is it time for vitamin B-12 fortification? What are the questions?Am J Clin Nutr. 2009;89(2):712S–716S.
11.
RacusinDStevensBCampbellGAagaardKM. Obesity and the risk and detection of fetal malformations. Semin Perinatol. 2012;36(3):213–221.
12.
CarmichaelSLRasmussenSAShawGM. Prepregnancy obesity: a complex risk factor for selected birth defects. Birth Defects Res A Clin Mol Teratol. 2010;88(10):804–810.
13.
MoleyKHChiMMKnudsonCMKorsmeyerSJMuecklerMM. Hyperglycemia induces apoptosis in preimplantation embryos through cell death effector pathways. Nature Med. 1998;4(12):1421–1424.
14.
ChangTILoekenMR. Genotoxicity and diabetic embryopathy: impaired expression of developmental control genes as a cause of defective morphogenesis. Semin Repord Endocrinol. 1999;17(2):153–165.
15.
MoleyKH. Hyperglycemia and apoptosis: mechanisms for congenital malformations and pregnancy loss in diabetic women. Trends Endocrinol Metab. 2001;12(2):78–82.
16.
FineELHoralMChangTIFortinGLoekenMR. Evidence that elevated glucose causes altered gene expression, apoptosis, and neural tube defects in a mouse model of diabetic pregnancy. Diabetes. 1999;48(812):2454–2462.
17.
FuJTaySSLingEADheenST. High glucose alters the expression of genes involved in proliferation and cell-fate specification of embryonic neural stem cells. Diabetologia. 2006;49(5):1027–1038.
18.
PhelanSAItoMLoekenMR. Neural tube defects in embryos of diabetic mice: role of the Pax-3 gene and apoptosis. Diabetes. 1997;46(7):1189–1197.
19.
YazdyMMLiuSMitchellAAWerlerMM. Maternal dietary glycemic intake and the risk of neural tube defects. Am J Epidemiol. 2010;171(4):407–414.
20.
DavidsonCMNorthrupHKingTMGenes in glucose metabolism and association with spina bifida. Reprod Sci. 2008;15(1):51–58.
21.
CarterTCPangilinanFTroendleJFEvaluation of 64 candidate single nucleotide polymorphisms as risk factors for neural tube defects in a large Irish study population. Am J Med Genet A. 2011;155A(1):14–21.
22.
GuilmatreASharpAJ. Parent of origin effects. Clin Genet. 2012;81(3):201–209.
23.
WeinbergCR. Methods for detection of parent-of-origin effects in genetic studies of case-parents triads. Am J Hum Genet. 1999;65(1):229–235.
24.
HagerRCheverudJMWolfJB. Maternal effects as the cause of parent-of-origin effects that mimic genomic imprinting. Genetics. 2008;178(3):1755–1762.
25.
WilkinsJFHaigD. What good is genomic imprinting: the function of parent-specific gene expression. Nat Rev Genet. 2003;4(5):359–368.
26.
ChristensenBArbourLTranPGenetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Am J Med Genet. 1999;84(2):151–157.
27.
DeanJCMooreSJOsborneAHoweJTurnpennyPD. Fetal anticonvulsant syndrome and mutation in the maternal MTHFR gene. Clin Genet. 1999;56(3):216–220.
28.
ChomczynskiPSacchiN. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162(1):156–159.
29.
HodgkinsonADPageTMillwardBADemaineAG. A novel polymorphism in the 5' flanking region of the glucose transporter (GLUT1) gene is strongly associated with diabetic nephropathy in patients with Type 1 diabetes mellitus. J Diabetes Complications. 2005;19(2):65–69.
30.
SoranzoNSannaSWheelerECommon variants at 10 genomic loci influence hemoglobin A1(C) levels via glycemic and nonglycemic pathways. Diabetes. 2010;59(12):3229–3239.
31.
SpielmanRSMcGinnisREEwensWJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet. 1993;52(3):506–516.
32.
DudbridgeF. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered. 2008;66(2):87–98.
33.
CordellHJBarrattBJClaytonDG. Case/pseudocontrol analysis in genetic association studies: a unified framework for detection of genotype and haplotype associations, gene-gene and gene-environment interactions, and parent-of-origin effects. Genet Epidemiol. 2004;26(3):167–185.
34.
BlandJMAltmanDG. Statistics notes. The odds ratio. BMJ. 2000;320(7247):1468.
35.
GuoXGengMDuG. Glucose transporter 1, distribution in the brain and in neural disorders: its relationship with transport of neuroactive drugs through the blood-brain barrier. Biochem Genet. 2005;43(3-4):175–187.
36.
TrocinoRAkazawaSTakinoHCellular-tissue localization and regulation of the GLUT-1 protein in both the embryo and the visceral yolk sac from normal and experimental diabetic rats during the early postimplantation period. Endocrinology. 1994;134(2):869–878.
37.
GaoLLvCXuCDifferential regulation of glucose transporters mediated by CRH receptor type 1 and type 2 in human placental trophoblasts. Endocrinology. 2012;153(3):1464–1471.
38.
MoritaYTsutsumiOOkaYTaketaniY. Glucose transporter GLUT1 mRNA expression in the ontogeny of glucose incorporation in Mouse preimplantation embryos. Biochem Biophys Res Commun. 1994;199(3):1525–1531.
39.
MatsumotoKAkazawaSIshibashiMAbundant expression of GLUT1 and GLUT3 in rat embryo during the early organogenesis period. Biochem Biophys Res Commun. 1995;209(1):95–102.
40.
ChiMMPingsterhausJCarayannopoulosMMoleyKH. Decreased glucose transporter expression triggers BAX-dependent apoptosis in the murine blastocyst. J Biol Chem. 2000;275(51):40252–40257.
41.
HeiligCWSaundersTBrosiusFC 3rdGlucose transporter-1-deficient mice exhibit impaired development and deformities that are similar to diabetic embryopathy. Proc Natl Acad Sci U S A. 2003;100(26):15613–15618.
42.
IllsleyNP. Glucose transporters in the human placenta. Placenta. 2000;21(1):14–22.
43.
BianchiMMagnaniM. Hexokinase mutations that produce nonspherocytic hemolytic anemia. Blood Cells Mol Dis. 1995;21(1):2–8.
44.
FarooqiISO'RahillyS. Mutations in ligands and receptors of the leptin-melanocortin pathway that lead to obesity. Nat Clin Pract Endocrinol Metab. 2008;4(10):569–577.
45.
MansourEPereiraFGAraújoEPLeptin inhibits apoptosis in thymus through a janus kinase-2-independent, insulin receptor substrate-1/phosphatidylinositol-3 kinase-dependent pathway. Endocrinology. 2006;147(11):5470–5479.
46.
ZhangYHuangC. Targeting adipocyte apoptosis: a novel strategy for obesity therapy. Biochem Biophys Res Commun. 2012;417(1):1–4.
47.
BeatyTHHetmanskiJBZeigerJSTesting candidate genes for non-syndromic oral clefts using a case-parent trio design. Genet Epidemiol. 2002;22(1):1–11.
48.
ValenzuelaCYAcuñaMPHarbZ. Sociogenetic gradient in the Chilean population. Rev Med Chil. 1987;115(4):295–299.
49.
ValenzuelaCY. On sociogenetic clines. Ethol Sociobiol. 1988;9(5):259–268.
50.
SuazoJSantosJLCarreñoHJaraLBlancoR. Linkage disequilibrium between MSX1 and non-syndromic cleft lip/palate in the Chilean population. J Dent Res. 2004;83(10):782–725.
51.
TorielloHVHigginsJV. Possible causal heterogeneity in spina bifida cystica. Am J Med Genet. 1985;21(1):13–20.
52.
TorielloHVHigginsJV. Occurrence of neural tube defects among first-, second-, and third-degree relatives of probands: results of a United States study. Am J Med Genet. 1983;15(4):601–606.
53.
HallJSolehdinF. Folic acid for the prevention of congenital anomalies. Eur J Pediatr. 1998;157(6):445–450.
54.
DrainerEMayHMTolmieJL. Do familial neural tube defects breed true?J Med Genet. 1991;28(9):605–608.
55.
GarabedianBHFraserFC. Upper and lower neural tube defects: an alternate hypothesis. J Med Genet. 1993;30(10):849–851.
56.
KällénBCocchiGKnudsenLBInternational study of sex ratio and twinning of neural tube defects. Teratology. 1994;50(5):322–331.
57.
SellerMJ. Sex, neural tube defects, and multisite closure of the human neural tube. Am J Med Genet. 1995;58(4):332–336.
58.
DolkHDe WalsPGillerotYHeterogeneity of neural tube defects in Europe: the significance of site of defect and presence of other major anomalies in relation to geographic differences in prevalence. Teratology. 1991;44(5):547–559.
Van AllenMIKalousekDKChernoffGFEvidence for multi-site closure of the neural tube in humans. Am J Med Genet. 1993;47(5):723–743.
61.
LindhoutDOmtzigtJGCornelMC. Spectrum of neural-tube defects in 34 infants prenatally exposed to antiepileptic drugs. Neurology. 1992;42(4 suppl 5):111–118.
62.
EscamillaMAMcInnesLASpesnyMAssessing the feasibility of linkage disequilibrium methods for mapping complex traits: an initial screen for bipolar disorder loci on chromosome 18. Am J Hum Genet. 1999;64(6):1670–1678.
63.
MartinERLaiEHGilbertJRSNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease. Am J Hum Genet. 2000;67(2):383–394.
64.
AkeyJJinLXiongM. Haplotypes vs single marker linkage disequilibrium tests: what do we gain?Eur J Hum Genet. 2001;9(4):291–300.
65.
SchorkNJ. Genetics of complex disease: approaches, problems, and solutions. Am J Respir Crit Care Med. 1997;156(4 pt 2):S103–S109.
66.
BarrosoILuanJMiddelbergRPCandidate gene association study in type 2 diabetes indicates a role for genes involved in b-cell function as well as insulin action. PLoS Biol. 2003;1(1):41–45.
67.
PernegerTV. Adjusting for multiple testing in studies is less important than other concerns. Brit Med J. 1999;318(7193):1288.
68.
HiekkalinnaTGöringHHLambertBOn the statistical properties of family-based association tests in datasets containing both pedigrees and unrelated case-control samples. Eur J Hum Genet. 2012;20(2):217–223.
69.
LairdNMHorvathSXuX. Implementing a unified approach to family-based tests of association. Genet Epidemiol. 2000;19(suppl 1):S36–S42.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
